Japan News
-
Takeda gets go ahead for teduglutide in Europe
Japan | News | By BioSpectrum Bureau | 0 Comment | 05 Sep, 2012
Singapore: The European Commission (EC) has granted European market authorization for the medicinal product teduglutide ...Read more
-
Astellas, UMN pharma to curb influenza in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 03 Jun, 2014
Singapore: In a bid to curtail the growing cases of influenza in Japan, Astellas announced that it has submitted an app...Read more
-
Big Pharma continues acquisitions
Japan | Analysis | By BioSpectrum Bureau | 0 Comment | 19 Jun, 2012
The first quarter of 2011 witnessed major deals in the global pharmaceutical space, with April proving to be a big month...Read more
-
Ranbaxy aiming to sell its generics in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 18 Nov, 2013
Singapore: Leading Indian generic drug maker, Ranbaxy Laboratories, along with its owners, Japan's second largest pharma...Read more
-
Daiichi Sankyo and Asubio merge to streamline operations
Japan | News | By BioSpectrum Bureau | 0 Comment | 05 Apr, 2015
Daiichi Sankyo Inc., the US subsidiary of Daiichi Sankyo Company Ltd, will merge with its US-based sister company, Asubi...Read more
-
What functional roles do CROs play in APAC?
Japan | Analysis | By BioSpectrum Bureau | 4 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
-
Astellas joins hands with Tecnofarma International
Japan | News | By BioSpectrum Bureau | 0 Comment | 07 Jun, 2013
Singapore: The US subsidiary of Japanese drug major Astellas Pharma has entered into a distribution agreement with Tecno...Read more
-
BSA-CMR Survey: New CRO players emerge in APAC
Japan | Analysis | By BioSpectrum Bureau | 4 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
-
Alchemia gets US patent for oncology platform technology
Japan | News | By BioSpectrum Bureau | 0 Comment | 06 Mar, 2013
Singapore: Brisbane-based drug discovery and development company Alchemia has been granted a key US patent critical to ...Read more
-
Japan to develop vaccine for H7N9 bird flu
Japan | News | By BioSpectrum Bureau | 0 Comment | 03 Sep, 2013
Singapore: A panel of experts at the Health, Labor and Welfare Ministry of Japan will start producing a vaccine for the ...Read more
-
Kitasato Daiichi Sankyo to shut animal vaccine unit
Japan | News | By BioSpectrum Bureau | 0 Comment | 21 Sep, 2012
Singapore: Daiichi Sankyo's animal vaccine unit, Kitasato Daiichi Sankyo Vaccine is discontinuing its animal vaccine bus...Read more
-
OptiMedica expands footprint in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 15 Aug, 2012
Singapore: Global ophthalmic company OptiMedica has expanded international market adoption of its Catalys Precision Las...Read more
-
WaferGen, Qiagen sign Next-Gen sequencing deal
Japan | News | By BioSpectrum Bureau | 0 Comment | 20 Feb, 2013
Singapore: WaferGen Bio-systems announced a co-marketing agreement with Qiagen for the promotion of certain products in ...Read more
-
Novartis's Ultibro Breezhaler receives EC, Japanese nod
Japan | News | By BioSpectrum Bureau | 0 Comment | 26 Sep, 2013
Singapore: Novartis has announced that the European Commission has approved once-daily Ultibro Breezhaler (indacaterol 8...Read more
-
Shimadzu India aims at 15-20% growth
Japan | Influencers | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2012
With a view of expanding their customer base, Shimadzu Analytical India has been taking concrete steps towards connectin...Read more
-
Ex-GSK boss promoted as Takeda's CEO
Japan | Influencers | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2014
Singapore: Japan's Takeda Pharmaceutical has promoted Mr Christophe Weber, representative director, president and chief ...Read more
-
Millennium starts ph III trial for multiple myeloma drug
Japan | News | By BioSpectrum Bureau | 0 Comment | 02 Jul, 2012
Singapore: Millennium: The Takeda Oncology Company, has initiated an international phase III clinical trial evaluating M...Read more
-
Astellas looks to sell dermatology assets: Sources
Japan | News | By BioSpectrum Bureau | 0 Comment | 19 Jun, 2013
Singapore: Japan-based drugmaker Astellas Pharma is planning to sell its dermatology portfolio, which could be worth bet...Read more
